AKT1 and lung cancer: Since the activation of the PI3K/AMPK/AKT/mTOR pathway is shown to cause the development of a more aggressive lung cancer phenotype which correlates to poor prognosis for patients [36], we assessed whether 21α-MMD affects these signals.